letrozole

Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma
Munekage Yamaguchi, Chimeddulam Erdenebaatar, Fumitaka Saito, Takeshi Motohara, Yo Miyahara, Hironori Tashiro, Hidetaka Katabuchi

International Journal of Gynecologic Cancer Nov 2015, 25 (9) 1645-1651; DOI: 10.1097/IGC.0000000000000557
Aromatase Inhibitor Letrozole in Synergy With Curcumin in the Inhibition of Xenografted Endometrial Carcinoma Growth
Yuan-Jiao Liang, Qun Hao, Yuan-Zhe Wu, Qiao-Lian Wang, Jian-Dong Wang, Ya-Li Hu

International Journal of Gynecologic Cancer Oct 2009, 19 (7) 1248-1252; DOI: 10.1111/IGC.0b013e3181b33d76
Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozole
X. WANG, S. TANGJITGAMOL, J. LIU, J. J. KAVANAGH

International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1243-1248; DOI: 10.1136/ijgc-00009577-200511000-00050
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group
B. B. Y. Ma, A. Oza, E. Eisenhauer, G. Stanimir, M. Carey, W. Chapman, E. Latta, K. Sidhu, J. Powers, W. Walsh, A. Fyles

International Journal of Gynecologic Cancer Jun 2004, 14 (4) 650-658; DOI: 10.1136/ijgc-00009577-200407000-00013

Main menu